Akèy › Kansè (tout kalite)
Etid klinik pou Kansè (tout kalite) ap rekrite nan Etazini
619 etid pou Kansè (tout kalite) ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC59 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
- St. Louis, MO46 etid
- San Antonio, TX41 etid
- Pittsburgh, PA41 etid
- Mountain View, CA40 etid
- Tampa, FL39 etid
- Columbus, OH38 etid
- Dallas, TX37 etid
- Baltimore, MD37 etid
- Cleveland, OH36 etid
- Miami, FL36 etid
- Aurora, CO35 etid
- San Francisco, CA34 etid
- Portland, OR34 etid
- New Haven, CT33 etid
- Edison, NJ32 etid
- Baldwin Park, CA32 etid
- San Diego, CA32 etid
- Memphis, TN31 etid
- Rochester, MN30 etid
- Birmingham, AL30 etid
- Jacksonville, FL29 etid
- Detroit, MI29 etid
- Grand Rapids, MI28 etid
- Charlotte, NC27 etid
- Cincinnati, OH27 etid
- Salt Lake City, UT27 etid
- Queens, NY25 etid
- Ann Arbor, MI25 etid
Pa eta
- Alabama36 etid
- Alaska3 etid
- Arizona50 etid
- Arkansas22 etid
- Ayiti13 etid
- Colorado55 etid
- Connecticut44 etid
- Delaware9 etid
- Distrik Columbia25 etid
- Florid128 etid
- Georgia64 etid
- Idaho4 etid
- Illinois67 etid
- Indiana31 etid
- Iowa17 etid
- Kalifòni174 etid
- Kansas19 etid
- Kentucky26 etid
- Lwizyàn19 etid
- Main5 etid
- Maryland70 etid
- Massachusetts96 etid
- Michigan74 etid
- Minnesota50 etid
- Mississippi8 etid
- Missouri57 etid
- Montana3 etid
- Nebraska22 etid
- Nevada13 etid
- New Hampshire12 etid
- New Jersey61 etid
- New Mexico16 etid
- New York141 etid
- North Carolina90 etid
- North Dakota11 etid
- Ohio85 etid
- Oklahoma15 etid
- Oregon41 etid
- Pennsylvania103 etid
- Rhode Island12 etid
- South Carolina29 etid
- South Dakota13 etid
- Tennessee91 etid
- Texas184 etid
- Utah39 etid
- Vermont7 etid
- Virginia71 etid
- Washington58 etid
- West Virginia7 etid
- Wisconsin39 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Oct 1, 2026 · NCT07024784A Natural History Study of Metabolic Sizing in Health and Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 99 · Tout sèks · Mizajou Oct 1, 2026 · NCT05398783A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07209111TLR9 Immunotherapy for Peritoneal Carcinomatosis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07658196A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07155187Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07566156A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05382559Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
Ap rekriteEtid obsèvasyon
Laj 20 a 89 · Fanm · Mizajou Sep 30, 2026 · NCT07023887Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07848841A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471Daily Hand-Held Vibration Therapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT04207437Clinical and Genetic Studies of Li-Fraumeni Syndrome
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Sep 30, 2026 · NCT01443468TREC@TAMU Cancer Prevention Registry and Repository
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06826014Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT00026884A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
Ap rekrite
Laj 20 a 89 · Fanm · Mizajou Sep 30, 2026 · NCT07698314uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07410117REC-7735 in Participants With Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07819136A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07409246Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07529808A Study of PHN-012 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07744126Registry Study for Radiation Therapy Outcomes
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT01255748A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07578571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00006518Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.